Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Pipeline Review, H2 2016

MarketResearchReports.biz has recently announced the addition of a market study “ Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Pipeline Review, H2 2016 ”, is a comparative analysis of the global market.

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Pipeline Review, H2 2016

Summary

Global Markets Directs, Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Pipeline Review, H2 2016, provides in depth analysis on Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted pipeline therapeutics.

The report provides comprehensive information on the Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics development and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/873433

Note:

*Certain sections in the report may be removed or altered based on the availability and relevance of data.

*Updated report will be delivered in 48 hours of order confirmation.

Scope

– The report provides a snapshot of the global therapeutic landscape for Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10)

– The report reviews Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved in Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics and enlists all their major and minor projects

– The report assesses Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news and deals related to Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand the targeted therapy areas and indications for Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10)

– Identify the use of drugs for target identification and drug repurposing

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) development landscape

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table Of Content

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Global Markets Direct Report Coverage 7

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Overview 8

Therapeutics Development 9

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Products under Development by Stage of Development 9

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Products under Development by Therapy Area 10

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Products under Development by Indication 11

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Pipeline Products Glance 13

Late Stage Products 13

Early Stage Products 14

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Products under Development by Companies 15

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Products under Development by Universities/Institutes 18

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Therapeutics Assessment 20

Assessment by Monotherapy/Combination Products 20

Assessment by Mechanism of Action 21

Assessment by Route of Administration 23

Assessment by Molecule Type 25

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Companies Involved in Therapeutics Development 27

Aptevo Therapeutics Inc 27

ARMO Biosciences, Inc. 28

BioMAS Ltd. 29

Biotest AG 30

enGene, Inc 31

Intrexon Corporation 32

LEO Pharma A/S 33

Merck & Co., Inc. 34

P2D Bioscience 35

Pfizer Inc. 36

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) – Drug Profiles 37

AM-0010 – Drug Profile 37

Product Description 37

Mechanism Of Action 37

R&D Progress 37

ANV-103 – Drug Profile 40

Product Description 40

Mechanism Of Action 40

R&D Progress 40

Biologic to Activate Glutamic Acid Decarboxylase and IL-10 for Type 1 Diabetes – Drug Profile 41

Product Description 41

Mechanism Of Action 41

R&D Progress 41

Biologic to Target Insulin Receptor and IL-10 for Type 1 Diabetes – Drug Profile 42

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Read our latest Press Releases at http://www.marketresearchreports.biz/pressreleases

Contact

State Tower

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA: Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

Email: sales@marketresearchreports.biz

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

banner